Cargando…

Following the Clues: Usefulness of Biomarkers of Neuroinflammation and Neurodegeneration in the Investigation of HTLV-1-Associated Myelopathy Progression

Human T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a neurodegenerative disease due to axonal damage of the corticospinal secondary to an inflammatory response against infected T-cells. In the present work, we aimed to evaluate biomarkers of neu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Souza, Flávia dos Santos, Freitas, Nicole Lardini, Gomes, Yago Côrtes Pinheiro, Torres, Rafael Carvalho, Echevarria-Lima, Juliana, da Silva-Filho, Isaac Lima, Leite, Ana Claudia Celestino Bezerra, de Lima, Marco Antonio Sales Dantas, da Silva, Marcus Tulius Teixeira, Araújo, Abelardo de Queiroz Campos, Espíndola, Otávio Melo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576432/ https://www.ncbi.nlm.nih.gov/pubmed/34764955 http://dx.doi.org/10.3389/fimmu.2021.737941

Ejemplares similares

Chitotriosidase 1 in the cerebrospinal fluid as a putative biomarker for HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) progression
por: Gomes, Yago Côrtes Pinheiro, et al.
Publicado: (2022)

Lessons from the Cerebrospinal Fluid Analysis of HTLV-1-Infected Individuals: Biomarkers of Inflammation for HAM/TSP Development
por: Freitas, Nicole Lardini, et al.
Publicado: (2022)

Cerebrospinal fluid findings in neurological diseases associated with COVID-19 and insights into mechanisms of disease development
por: Espíndola, Otávio Melo, et al.
Publicado: (2021)

Loop-Mediated Isothermal Amplification (LAMP) Assay for Rapid and Accurate Confirmatory Diagnosis of HTLV-1/2 Infection
por: Gomes, Yago, et al.
Publicado: (2020)

Patients with COVID-19 and neurological manifestations show undetectable SARS-CoV-2 RNA levels in the cerebrospinal fluid
por: Espíndola, Otávio de Melo, et al.
Publicado: (2020)

Isolated intracranial hypertension associated with COVID-19
por: Silva, Marcus Tulius T, et al.
Publicado: (2020)

HTLV-1 p12 modulates the levels of prion protein (PrP(C)) in CD4(+) T cells
por: Silva De Castro, Isabela, et al.
Publicado: (2023)

Protein Profile of Blood Monocytes is Altered in HTLV-1 Infected Patients: Implications for HAM/TSP Disease
por: Echevarria-Lima, Juliana, et al.
Publicado: (2018)

INTERFERON BETA-1A TREATMENT IN HTLV-1-ASSOCIATED MYELOPATHY/TROPICAL SPASTIC PARAPARESIS: A CASE REPORT
por: Viana, Graça Maria de Castro, et al.
Publicado: (2014)

Peripheral facial nerve palsy associated with COVID-19
por: Lima, Marco A., et al.
Publicado: (2020)

SARS-CoV-2: Should We Be Concerned about the Nervous System?
por: Silva, Marcus Tulius T., et al.
Publicado: (2020)

Amendment on brain signal intensity on Magnetic Resonance Imaging of asymptomatic HTLV-1 seropositive and HTLV-1 associated myelopathy
por: Bastos, Rafael HC, et al.
Publicado: (2014)

Cardiovascular risk profile in patients with myelopathy associated with HTLV-1()
por: Prado, Fabio Luís Silva do, et al.
Publicado: (2017)

Neurodevelopmental Clues to Neurodegeneration
por: Schor, Nina F., et al.
Publicado: (2021)

Aquaporin-4 Antibodies Are Not Related to HTLV-1 Associated Myelopathy
por: von Glehn, Felipe, et al.
Publicado: (2012)

Synthetic (E)-3-Phenyl-5-(phenylamino)-2-styryl-1,3,4-thiadiazol-3-ium Chloride Derivatives as Promising Chemotherapy Agents on Cell Lines Infected with HTLV-1
por: Sousa-Pereira, Danilo, et al.
Publicado: (2020)

Neurofilament Light in CSF and Plasma Is a Marker of Neuronal Damage in HTLV-1–Associated Myelopathy and Correlates With Neuroinflammation
por: Rosadas, Carolina, et al.
Publicado: (2021)

Neuroinflammation and Neurodegeneration: Pinpointing Pathological and Pharmacological Targets
por: de Oliveira, Antonio Carlos Pinheiro, et al.
Publicado: (2015)

Susceptibility of Primary HTLV-1 Isolates from Patients with HTLV-1-Associated Myelopathy to Reverse Transcriptase Inhibitors
por: Macchi, Beatrice, et al.
Publicado: (2011)

Absence of HTLV‐II Co‐infection in HTLV‐I‐associated Myelopathy Patients
por: Miyamoto, Kanji, et al.
Publicado: (1992)

Smell dysfunction in COVID-19 patients: More than a yes-no question
por: Lima, Marco A., et al.
Publicado: (2020)

Sensitivity and specificity of spinal cord Magnetic Resonance Imaging in the diagnosis of HTLV-1 associated myelopathy
por: Romanelli, Luiz CF, et al.
Publicado: (2014)

Telephone Screening of Cognitive Status (TICS) in severe COVID-19 patients: Utility in the era of social isolation
por: Soldati, Ana Beatriz, et al.
Publicado: (2021)

Treatment of patients with HTLV-1-associated myelopathy with methotrexate
por: Ahmed, S, et al.
Publicado: (2014)

Impaired flexibility in patients with tropical spastic paraparesis/HTLV-associated myelopathy: evaluation via pendulum fleximeter
por: Landim, Caroline, et al.
Publicado: (2023)

Early diagnosis of HTLV-1-associated myelopathy (HAM/TSP) in HTLV-1 carrier clinic
por: Matsuzaki, Toshio, et al.
Publicado: (2014)

HTLV-1-associated infective dermatitis and probable HTLV-1- associated myelopathy in an adolescent female
por: Steglich, Raquel Bisacotti, et al.
Publicado: (2015)

New Perspectives about Drug Candidates Targeting HTLV-1 and Related Diseases
por: da Silva, Milena Cristina Martins, et al.
Publicado: (2023)

Iron, Neuroinflammation and Neurodegeneration
por: Ward, Roberta J., et al.
Publicado: (2022)

Lack of association between single-nucleotide polymorphisms of pro- and anti-inflammatory cytokines and HTLV-1-associated myelopathy / tropical spastic paraparesis development in patients from Rio de Janeiro, Brazil
por: Schor, Doris, et al.
Publicado: (2018)

The SAMHD1 rs6029941 (A/G) Polymorphism Seems to Influence the HTLV-1 Proviral Load and IFN-Alpha Levels
por: Queiroz, Maria Alice Freitas, et al.
Publicado: (2020)

Comparison of walking measures in patients with HTLV-1 Associated Myelopathy
por: Adonis, Adine, et al.
Publicado: (2015)

CT Chest and pulmonary functional changes in patients with HTLV-associated myelopathy in the Eastern Brazilian Amazon
por: Magno Falcão, Luiz Fábio, et al.
Publicado: (2017)

The Impact of Immune Response on HTLV-I in HTLV-I-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP)
por: Rafatpanah, Houshang, et al.
Publicado: (2013)

Correction: CT Chest and pulmonary functional changes in patients with HTLV-associated myelopathy in the Eastern Brazilian Amazon
por: Magno Falcão, Luiz Fábio, et al.
Publicado: (2017)

Increased seroreactivity to HERV-K10 peptides in patients with HTLV myelopathy
por: Perzova, Raisa, et al.
Publicado: (2013)

Familial Clusters of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
por: Nozuma, Satoshi, et al.
Publicado: (2014)

Effect of Pulsed Methylprednisolone on Pain, in Patients with HTLV-1-Associated Myelopathy
por: Buell, Kevin G., et al.
Publicado: (2016)

Median Nerve Somatosensory Evoked Potential in HTLV-I Associated Myelopathy
por: Boostani, Reza, et al.
Publicado: (2016)

Early-Onset HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
por: Schwalb, Alvaro, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dvt2q0f6fu9173dcgmhjf69tq0